About
Team
Management Team
Supervisory Board
Scientific Advisory Board
Erasmus MC Partner
Science
How TCR-T cell therapy works
Next-generation T cell therapy
Pipeline
Investors
News
Contact
Our latest news
Pan Cancer T Appoints Dr. Rachel Abbott as Chief Scientific Officer
Pan Cancer T Extends Seed Financing Round with Additional Funding from Existing Shareholders and New Investor Thuja Capital
Pan Cancer T celebrates 1-year anniversary!
TCR T cells towards solid tumors: perspective on pitfalls and opportunities
Pan Cancer T is awarded with Axon Innovation for Health Award 2021
Pan Cancer T B.V. Appoints Seasoned Entrepreneurs and Executives to its Supervisory Board and Elects its Chairman
Press Release: Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center
Health~Holland public-private-partnership grant award of 0.9 M€
